Video & Transcript : 'pharmaceutical regulation' :

Page 20 of 500
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Economic Development and Emerging Technologies Jun 21st, 2026 at 12:30 pm

Joint Committee on Economic Development and Emerging Technologies

Transcript Highlights:
  • And in 2021, Vertex Pharmaceuticals invested almost a billion dollars in CRISPR Therapeutics to bring
  • And in 2021, Vertex Pharmaceuticals invested almost a billion dollars in CRISPR therapeutics to bring
  • So these discoveries were licensed to biotech and pharmaceutical companies to develop drugs that would
  • They can't make enough money off of a pharmaceutical that's only going to treat a few 10,000 people or
  • This information will lead to faster and more effective recommendations for regulation and management
Summary: The committee on Economic Development held a hearing on the DRIVE Act, a proposal to invest $400 million in Massachusetts research and innovation without new taxes. Governor Healey and administration officials said the bill would direct $200 million to public higher education research and regional partnerships and $200 million to a research funding pool for hospitals, universities, and other institutions, with the goal of retaining talent, leveraging private and philanthropic dollars, and offsetting major federal R&D cuts. They argued that research is a core economic engine for the state, supporting jobs across labs, construction, services, and surrounding businesses, and said the bill would help protect the Commonwealth’s tax base and competitiveness during a period of federal uncertainty and cuts to SNAP, Medicaid, and other programs. Committee members raised concerns about whether Fair Share surtax dollars should instead be used for K-12 and other community needs, whether the proposal is enough given the scale of lost federal grants, and how the money would be allocated. The governor responded that the funds are one-time surplus dollars, that most surtax revenue already supports education, and that the bill is meant as a bridge to stabilize public higher education and research. She also said the legislation includes a review board and could support a revolving or matched-fund approach in some cases. Several members pressed for more detail on selection criteria, future funding, and whether private companies and large endowments should contribute more. University of Massachusetts leaders and researchers testified that federal grant cancellations and delays are already causing layoffs, furloughs, rescinded admissions, and lost research capacity. UMass officials said the bill would help preserve faculty, postdocs, graduate students, and research programs in medicine, climate science, marine science, Braille instruction, and AI decision-making. They emphasized that the funding should be merit-based and that the state needs to act quickly to prevent talent from leaving Massachusetts. Business, labor, and industry groups, including MassBio, the Massachusetts Taxpayers Foundation, AIM, the AFL-CIO, and Building Trades, supported the bill, saying it would protect jobs, sustain the innovation ecosystem, and reinforce Massachusetts’ national leadership in research and life sciences. No vote was taken in the hearing.
AL

Alabama 2025 Regular Session

Alabama Senate Children and Youth Health Committee Apr 9th, 2025

Children and Youth Health

Transcript Highlights:
  • responsible between responsible hemp products that are manufactured in federal compliance with strict regulation
  • We support regulation. We do. But please don't regulation. We do.
  • So the research in Birmingham has studied just about every pharmaceutical clinical trial.
  • We should be for regulating. We're for... ...be we're for regulating. We're for 21 or older.
  • libertarian bent, and I understand the government can meddle with too many things, but overall we regulate
Bills: SB274
ID

Idaho 2026 Regular Session

Jan 22nd, 2026

Transcript Highlights:
  • Pharmaceuticals. And we spend an exorbitant amount of pharmaceuticals.
  • Pharmaceuticals. And we spend an exorbitant amount of pharmaceuticals.
  • personal stories so we're not getting them lost in all these big numbers and concepts and federal regulations
  • personal stories so we're not getting them lost and all these big numbers and concepts and federal regulations
Summary: The committee heard a budget presentation on the Division of Medicaid within the Department of Health and Welfare, including an overview of the division’s five programs, staffing, spending trends, and the large share of the budget that goes to trust and benefit payments. Ms. Williamson explained the difference between ongoing and one-time enhancements, the role of population forecast adjustments, and why the fiscal year 2026 and 2027 numbers change significantly. Members asked about the growth in the budget, the FMAP match rate, the impact of provider rate changes, and the shift of some positions into Medicaid from other divisions after last year’s reorganization. A major topic was House Bill 345 and related budget changes, including the hospital assessment fund alignment, the 4% provider rate reduction, and the effect on Medicaid expansion and other populations. The committee discussed the decline in expansion enrollment, rising costs in traditional Medicaid populations, and the governor’s recommendation to offset part of the 2027 increase with additional reductions. Members raised concerns about access to care, especially for dental, behavioral health, developmental disability, and home- and community-based services, while the deputy director said the department is trying to contain costs through prior authorization, fraud and abuse work, and policy changes. The committee also focused on the MMIS replacement project, which is in year four of a five-year procurement and is funded through dedicated and federal dollars tied to milestones. Another significant item was estate recovery, where the department requested funding to replace an outdated case management system and add contractor support to address a backlog of roughly 20,000 cases; members questioned the return on investment and asked for more detail on the software and staffing split. The deputy director also explained the federally qualified health center reconciliation issue, saying the state had not been properly paying change-in-scope amounts and is now using a new process with interim payments and later reconciliation. In addition, lawmakers asked about program integrity staffing, the use of AI, and whether the department could better target fraud, waste, and abuse investigations. The deputy director said the department is reviewing AI use cautiously and sees opportunities for it in claims review and anomaly detection, but emphasized that the current request is for dedicated receipt authority rather than general funds. No formal votes were taken in the excerpt, but the committee received the presentation, asked extensive questions, and was told that some follow-up information would be provided later.
WA

Washington 2025-2026 Regular Session

Senate Floor Session Feb 10th, 2026

Washington Senate Floor Meeting

Transcript Highlights:
  • An act relating to the Department of Labor and Industries' authority to enact rules related to regulation
  • An act relating to the Department of Labor and Industries' authority to enact rules related to regulating
  • There is no indication that the federal government is going to change any of their regulations in regard
  • Corrections pharmacy intended for purchasing pharmacist... ...pharmacy intended for purchasing pharmaceuticals
  • President, that would actually establish a state pharmaceutical distribution facility or state pharmacy
Summary: The Senate opened with roll call, the pledge, prayer, and recognition of guests from the Sikh Coalition and Kalsa Gramath Center. Members then approved the journal and moved through committee reports and resolutions, including Senate Resolution 8678 honoring the Chimicum High School Marching Band for being selected to represent Washington in the 2026 National Independence Day Parade in Washington, D.C. The resolution was adopted unanimously, and the band and its supporters were recognized in the gallery. The chamber then confirmed two gubernatorial appointments to major health agencies. Ryan Moran was confirmed as Director of the Health Care Authority by a 49-0 vote, with supporters citing his Medicaid and health system experience and ability to provide stable leadership. Dennis Worsham was also confirmed as Secretary of Health by a 49-0 vote, with senators highlighting his long public health career, statewide outreach, and work on HIV/AIDS and community health. On legislation, the Senate passed Senate Bill 6011, expanding Court of Appeals bailiff authority to conduct threat assessments, and Senate Bill 5831, creating the Uniform Mortgage Modification Act. Senate Bill 6188, which expands Labor and Industries’ authority to update asbestos training and certification rules, passed 38-19 after an amendment to limit the bill to federal standards was rejected. Substitute Senate Bill 5917, concerning access to abortion medications through the Department of Corrections pharmacy, passed 32-17 after several Republican amendments were defeated. The Senate also passed In Gross Senate Bill 6024 on developmental disability services confidentiality and Substitute Senate Bill 6091 on prohibiting real estate brokers from marketing residential properties in exclusive private listings. Finally, Substitute Senate Bill 5840, adjusting campaign finance expenditure reporting deadlines, passed 46-3. After completing the day’s business, the Senate recessed for caucus and lunch until 1:15 p.m.
AZ

Arizona 2026 Regular Session

02/18/2026 - Senate Judiciary and Elections

Judiciary and Elections

Transcript Highlights:
  • I know the federal FDA or DEA does the regulations. Is this considered a narcotic by them?
  • Child safety caps, the things normal pharmaceuticals require anyway.
  • Child safety caps, the things normal pharmaceuticals require anyway.
  • Normal pharmaceuticals require anyway, so if that answers your question. Thank you.
  • We regulate it. I'm all for it.
WA

Washington 2025-2026 Regular Session

Senate Law & Justice Jan 19th, 2026 at 10:30 am

Law & Justice

Transcript Highlights:
  • Currently, collection agencies that might collect on a consumer debt are regulated by the State Collection
  • Medical, surgical, dental, chiropractic, hospital, optometric, potiatric, pharmaceutical, ambulance,
  • This bill regulates imitation firearms at the state level.
  • This bill regulates imitation firearms at the state level.
  • It does regulate BB guns. It specifically prohibits alterations of markings.
Bills: SB5720 , SB5833 , SB5936 , SB5993 , SB5735
TX

Texas 89th Regular

89th Legislative Session Apr 3rd, 2025

Texas House Floor Meeting

Transcript Highlights:
  • HB 4457 by Wajani Reling, the Innovation Weaver, is a certain issue in SLAWS regulations and requires
  • And plans for certain emission events or for the committee on environmental regulation It's before 483
  • by having a ruling to the funding mechanism for the Regulation of Workers' Compensation and Workers'
  • HB 4614 by Harless relating to the licensing and regulation of state correctional officers requiring
  • Ag 4633 by Goodwin, reeling the regulation of certain retail distributor centers for the Committee on
Bills: HB9 , HB22 , HB908 , HB1392
ID

Idaho 2026 Regular Session

Feb 26th, 2026

Agricultural Affairs

Transcript Highlights:
  • We need regulation.
  • listing out regulations.
  • We are grateful for the proposed regulation of 7-OH.
  • I'm always in favor of regulation.
  • Causing harm that is not regulated.
FL

Florida 2026 Regular Session

Appropriations Committee on Agriculture, Environment, and General Government Feb 25th, 2026

Appropriations Committee on Agriculture, Environment, and General Government

Transcript Highlights:
  • I served as a former regulator for several years before being in the private sector, specifically over
  • We've been applauded multiple times for how clear and well understood our rules and regulations are.
  • They're not regulated. They're, and oftentimes, fly-by-night.
  • The cost, the estimated aggregate increase in costs related to this MFL to regulated companies would
  • Johns River Water Management District to test the ability to remove all PFAS and pharmaceuticals.
Bills: S0598 , S0934 , S1260 , S1300 , S1452 , S1510 , S1566 , S1580 , S1668 , S7034
Summary: The committee first took up appointments, recommending confirmation of James Patrick Grambling and Brian J. Aungst on a single favorable vote. It then heard and approved several committee bills, including CS/CS/SB 1260 on building code inspections, which directs the Department of Management Services to contract with private providers for plan review and inspections; CS/SB 1668 on NICA, which updates benefits, oversight, funding, and immunity language; SB 1300 on a workforce/CDL training program for selected nonviolent inmates; CS/CS/SB 598 on funeral and cemetery services; CS/SB 1580 on illegal gaming enforcement; CS/SB 934 on Florida Keys affordable housing tax exemptions; and CS/CS/SB 1452, an agency bill updating DFS programs and licensing rules. Each of those bills was reported favorably after committee debate and, in several cases, amendments were adopted. The committee spent substantial time on CS/CS/SB 1510, the DEP package, which reorganizes environmental rulemaking and land acquisition authority, expands septic-to-sewer and nutrient-reduction requirements in sensitive areas, updates stormwater and resilience provisions, and revises related permitting and grant programs. Two amendments were adopted, including one adding solar-energy and stormwater-related provisions and another removing septic disclosure reporting language. Testimony included support from DEP and concerns from environmental advocates about septic timelines and implementation. The bill was ultimately reported favorably. The committee also considered CS/CS/SB 1566 on local government budget transparency, requiring counties and municipalities to post budgets and related materials online for extended periods in a standardized format. The League of Cities opposed the bill as an unfunded mandate, while the sponsor argued it would improve taxpayer access and accountability; the bill was reported favorably. Finally, the committee heard SB 7034, a rule ratification for minimum flows and levels for the lower Santa Fe and Ichetucknee rivers and priority springs, with testimony focused on the proposed Water First restoration strategy, conservation measures, and concerns about water quality, funding, and local opposition. The transcript ends during closing remarks on that ratification bill, before a final vote is shown.
MN

Minnesota 2025-2026 Regular Session

House Republican Media Availability 5/17/26

Minnesota House Floor Meeting

Transcript Highlights:
  • you discuss why 340B was not included in the help omnibus and what your discussions with the pharmaceutical
  • Uh, the discussions weren't with the pharmaceutical companies.
  • </c> have had with the pharmaceutical have had with the pharmaceutical industry.<00:19:55.000><c> Can
  • </c> discussions with the pharmaceutical discussions with the pharmaceutical industry<00:20:02.480><c
  • </c><00:20:05.960><c> The</c> pharmaceutical companies. The pharmaceutical companies.
CA
Transcript Highlights:
  • I wanted to also note there were questions about pharmaceuticals and spending in the pharmacy space.
  • So I think we're learning more, but I think pharmaceuticals have a lot to do with it, and then just the
  • You don't hear pharmaceutical companies shutting down a whole lot. Yeah, that...
  • through December 31, 2026, and federally approved for the same period under the current federal regulations
  • size of the current MCO... ...federally approved for the same period under the current federal regulations
Summary: The committee heard a budget oversight hearing on the Department of Health Care Services, focusing first on the overall Medi-Cal budget and a March General Fund loan to cover a current-year shortfall. DHCS said the 2025-26 budget proposal totals $193.4 billion, with Medi-Cal projected at $188.1 billion total funds and $42.1 billion General Fund, driven by higher enrollment, pharmacy costs, managed care growth, and costs tied to eligibility expansions and the COVID-era redetermination unwinding. The department said the $3.44 billion loan was needed to manage cash flow and ensure timely payments to providers and plans, while the LAO noted Medi-Cal’s cash-basis budgeting creates volatility and that more detailed estimates would come with the May Revision. Members discussed federal Medicaid threats, the need for transparency on cost drivers, and the impact of pharmacy spending, long-term care, and immigration-related coverage expansions. The second major topic was family health programs, including California Children’s Services, the continuous coverage unwinding, and opioid settlement fund spending. DHCS described CCS funding methodology changes, ongoing county stakeholder work, and a delayed rollout of CCS monitoring and oversight until July 1, 2025, while county representatives and advocates argued the program is underfunded and asked for more technical assistance and a delay in implementation. On the unwinding, the department explained that federal redetermination flexibilities helped maintain coverage after the pandemic, but the Governor’s budget proposes ending them at the end of June 2025; advocates urged making the flexibilities permanent to avoid coverage losses. For opioid settlement funds, DHCS and Finance said the budget increases funding for naloxone distribution while reducing other harm-reduction spending based on updated settlement revenues, prompting criticism from members and public commenters who argued the change would weaken effective harm-reduction programs. The hearing also included an update on Proposition 35 implementation. DHCS said the voter-approved measure continuously appropriates MCO tax revenues beginning in 2025, with up to $4.6 billion annually available for specified Medi-Cal and provider investments in 2025 and 2026, but implementation depends on consultation with the required stakeholder advisory committee. The department and LAO noted uncertainty about future federal rules affecting the MCO tax after 2026. Public testimony largely supported maintaining Medi-Cal expansions, protecting immigrant coverage, preserving harm-reduction funding, and increasing support for community health workers, pediatric dental care, and CCS county administration. No votes were taken during the portion of the hearing provided.
KY
Transcript Highlights:
  • Uh, these are real structure and regulation and funding opportunities and challenges that we're seeing
  • 23:45.440><c> real</c><00:23:45.760><c> structure</c><00:23:46.159><c> and</c><00:23:46.480><c> regulation
  • </c> these are real structure and regulation these are real structure and regulation and<00:23:47.360
  • But on the state funding side of this, if we're subsidizing trillion-dollar pharmaceutical companies
  • <00:35:57.599><c> companies</c><00:35:58.240><c> through</c> pharmaceutical companies through pharmaceutical
Summary: The Make America Healthy Kentucky Task Force met with a quorum, approved the minutes, and then heard a presentation on the state’s “food is medicine” work from Kentucky Hospital Association and Kentucky Department of Agriculture leaders, including Jim Muser, Holly Harris, and Commissioner Jonathan Shell. The chair framed the discussion around personal wellness, injury prevention, and the broader goal of improving health through better sleep, nutrition, and activity, then asked the presenters to describe current initiatives and any policy changes needed. The witnesses described a partnership linking hospitals and Kentucky farmers to improve health outcomes while supporting rural agriculture. They said the effort has moved beyond the pilot stage and now includes more than 40 hospitals statewide, with programs such as healthier hospital cafeterias, grab-and-go options, farmers markets at hospital sites, subsidized CSA boxes for employees, and medically tailored meals or groceries for patients with chronic conditions. ARH was highlighted as a leading model, with local food procurement, employee wellness efforts, and measurable outcome pilots, including a Russell County Hospital project focused on diabetes, heart disease, and obesity. They also emphasized barriers to scaling the model, including fragmented short-term funding, lack of reimbursement for food-as-medicine programs, and burdensome procurement and testing requirements that can make it difficult for small farmers to participate. The presenters said hospitals are using their own funds or temporary grants to sustain programs and argued that policy changes are needed to simplify sourcing, expand reimbursement pathways, and support clinical measurement of outcomes. No votes or formal actions beyond approving the minutes were taken during the portion provided.
US
Transcript Highlights:
  • Have you adhered to applicable laws and regulations governing conflicts of interest? Yes.
  • it is a threat to our readiness and to the potential health of our service members that DOD's pharmaceutical
  • For these reasons, the DoD report recommends boosting the production of finished drugs, active pharmaceuticals
  • , and other drugs. pharmaceutical ingredients, and other key starting materials so that we are making
Summary: The meeting primarily focused on military procurement and modernization, with significant discussions surrounding the Air Force's capabilities and strategic needs. Key topics included the urgent need for recapitalization of the Air Force's fighter squadrons, as well as the importance of integrating new technologies like autonomous systems to bolster military effectiveness. Several senators raised concerns about the current resources available to the Air National Guard and the potential loss of skilled service members if recapitalization plans are not swiftly developed. There were also discussions on the importance of maintaining air superiority in light of evolving threats, particularly from adversaries like China.
AZ

Arizona 2026 Regular Session

03/25/2026 - House Judiciary

Judiciary

Transcript Highlights:
  • The violation must be reported to the issuing jurisdiction and federal regulators, and the vehicle and
  • Second, it is one of the most heavily regulated substances in our state, especially when it comes to
  • When traditional pharmaceuticals would not touch her nausea, her doctor recommended that she return to
  • When traditional pharmaceuticals would not touch her nausea, her doctor recommended that she return to
  • through regulations, take other rights that these people have.
NM

New Mexico 2025 Regular Session

IC - Legislative Finance Aug 19th, 2025

Transcript Highlights:
  • That'll combine some regulations, specifically zoning and subdivision regulations, and the idea is to
  • I'm the Chief of Staff of the Public Regulation Commission.
  • Being a reliable partner in regulation, so you all know what you're going to get and our regulated entities
  • A lot of it depends on your regulation, right?
  • And that goes to the regulation. Mr.
MN

Minnesota 2025-2026 Regular Session

Committee on Commerce and Consumer Protection - 03/25/25

Commerce and Consumer Protection

Transcript Highlights:
  • </c><00:21:18.400><c> as</c> up with new laws and regulations as up with new laws and regulations as
  • </c><00:21:58.120><c> I'm</c> far more extensive new regulations I'm far more extensive new regulations
  • </c><01:12:11.880><c> CFR</c> standards with Federal Regulation CFR standards with Federal Regulation
  • </c><01:13:34.159><c> of</c> this would be updating our regulation of this would be updating our regulation
  • </c> the extent to which the pharmaceutical the extent to which the pharmaceutical Market<01:28:01.639
OK

Oklahoma 2026 Regular Session

Administrative Rules Apr 27th, 2026 at 10:30 am

Administrative Rules

Transcript Highlights:
  • The pharmaceutical industrial complex has devastated this community.
  • It's an old industry, but it's nascent in its regulation.
  • the cacophony of reports that we're hearing from the rank and file is that it's so much easier to regulate
  • And for that reason, because they don't feel like they're in an equal playing field in front of a regulator
  • agency so that we're fair to everyone and that no agency has an advantage over the people that they regulate
NY

New York 2025-2026 Regular Session

Senate Standing Committee on Finance - 05/12/2026

Finance

Transcript Highlights:
  • requiring prescription drug manufacturers to notify the Attorney General of arrangements between pharmaceutical
  • By no means a patent attorney, particularly in the field of pharmaceuticals, but my understanding from
  • duplicate process that the state is already governed by the federal government and we're dealing with pharmaceutical
  • It's been raised by the pharmaceutical industry that this may actually...
  • It's been raised by the pharmaceutical industry that this may actually... Thank you.
Committee: Senate Finance
Summary: The Senate Finance Committee, chaired for the day by Senator John Liu, took up a long agenda of bills covering labor and benefits, corrections, health, taxation, government transparency, and public services. Early measures included increasing short-term disability benefits, adjusting a poverty-level-related earned income disregard, expanding correctional health staffing review, and authorizing the Inspector General to investigate sexual assault complaints in correctional facilities; each of these advanced to the floor. The committee also advanced bills on ovarian cancer screening access, retirement system membership changes, a trail stewardship program, live agency representative access, FOIL/open meetings fee awards, a Harriman campus development plan, court data reporting, educator conventions, park water testing, an energy storage tax abatement, a Native American Affairs office, adult changing tables in public facilities, Medicaid Inspector General audit standards, remote training certification for agency personnel, newborn Gaucher disease testing, electronic self-exclusion requests for gambling, and child daycare inspections and opioid antagonist requirements. Several bills drew discussion. The prescription drug transparency bill (Print 488A) prompted questions about possible overlap with federal Hatch-Waxman/FTC oversight and whether a New York notice requirement could slow generic-drug settlements; sponsors and staff said it was intended as a supplemental transparency measure for consumers. The court reporting bill (Print 1849A) raised concerns about mandates on local governments, but supporters said it mainly required OCA to compile data in one format. The Medicaid local-share phaseout bill (Print 5519) generated the most debate, with supporters arguing it would provide major property tax relief and should be addressed in the budget, while opponents emphasized the need to curb Medicaid fraud, waste, and abuse first. Two major fiscal oversight proposals were defeated. Print 8661, which would have required the Comptroller to hire an independent private auditing firm to review state-funded programs for fraud and abuse, was opposed despite support from some members who argued outside auditing was overdue; it failed by one vote. Print 5519 was also ultimately defeated after a recount confirmed it lacked the required majority of the full 22-member committee. Most other bills were approved and sent either to the floor or, in the case of the drug transparency bill, to the Rules Committee.
CA
Transcript Highlights:
  • Those facilities are also regulated and certified according to federal requirements.
  • So you can see a significant increase in pharmaceutical expenditures.
  • Right, so the emergency regulations were pulled, but the pause or the moratorium is still in effect.
  • Okay, why did they pull the regulations? That is the Department of Public Health, and so I don't...
  • So what I'm saying is eventually, as OCA's regulations come into effect, you would start seeing that
Summary: The Assembly Budget Subcommittee on Health began with a hearing on the impacts of H.R. 1 on California health programs, focusing first on reproductive health state investments. HCAI outlined five state-funded reproductive health programs created after Dobbs, including uncompensated care, practical support, capital and clinical infrastructure, and workforce programs. Essential Access Health and Planned Parenthood testified that these funds have served hundreds of thousands of patients, but warned that the uncompensated care program is fully awarded and needs renewal, and that Title X and Medicaid-related federal uncertainty continues to threaten access. Members questioned who the uncompensated care program serves, why Medi-Cal covers a large share of abortions, and whether Planned Parenthood could expand prenatal services; public commenters urged continued support for reproductive health access. The committee then took up long-term care services and supports, starting with the HCBA and Assisted Living Waiver programs. DHCS reported large wait lists for both programs and said enrollment is limited by workforce and provider capacity, while LAO noted that increasing slots alone may not increase access without additional programmatic changes. Members pressed the department on whether more slots should be added given the lower cost of home- and community-based care compared with skilled nursing facilities, and public testimony argued that the wait lists should be reduced and that staffing concerns do not fully explain unused capacity. The committee also heard testimony on congregate living health facilities, where providers and a patient family described the homes as critical, lower-cost alternatives to nursing facilities for younger, medically complex people. Witnesses requested short-term bridge funding, while DHCS said it is proposing to transition CLFs into a managed care benefit by January 1, 2028, which would remove caps and expand access statewide. The final long-term care topic was PACE. DHCS explained that it has paused new PACE applications and service expansions for at least two years to reassess oversight capacity and develop a statewide strategic growth framework, while existing programs continue operating. CalPACE supported the pause as a planning measure but asked for four additional state nurse positions to reduce delays in level-of-care determinations and speed enrollment for frail older adults. Members shared personal stories about how PACE has helped family members and asked how the state will meet growing demand; DHCS said stakeholder engagement will begin later in the year and that some existing applications already in process will continue. Public commenters broadly supported PACE, HCBA, and CLF funding requests. The hearing then moved to the Department of Health Care Services’ 2026-27 Medi-Cal budget and related trailer bills. DHCS said Medi-Cal spending has grown due to coverage expansions, higher acuity, rising utilization, and especially pharmacy costs, and it described proposals to extend the current skilled nursing facility financing framework for one year while the state develops a new value-based payment strategy. LAO said most recent Medi-Cal spending growth has been driven more by higher per-enrollee costs than by caseload growth, with pharmacy spending growing especially quickly, and recommended better and more timely data to analyze the drivers. Members expressed concern about the rapid rise in Medi-Cal spending and asked for more detail on the largest cost increases.
WV

West Virginia 2026 Regular Session

Senate in Session Mar 10th, 2026 at 11:05 am

West Virginia Senate Floor Meeting

Transcript Highlights:
  • When myelin pharmaceuticals left, that took away about 3,500 jobs.
  • Engrossed Committee Substitute for House Bill 5430, relating to pharmaceutical benefits.
  • The bill regulates pharmacy benefits managers, PBMs.
  • The bill regulates pharmacy benefits managers, PBMs.
  • The bill regulates vape and smoke shops.